Abstract:Background Ferroptosis, a form of regulated cell death by lipid peroxidation, was currently considered as a key factor affecting the occurrence and progression in various cancers. Andrographolide (ADE), a major effective ingredient of Andrographis paniculate, has proven to have a substantial anti-tumor effect on multiple cancer types. However, the function and underlying mechanism of ADE in Non-Small Cell Lung Cancer remain unclear. Methods CCK8 assay, colony-formation assay, flow cytometry, scratch test, transwell assay, western blotting, ferroptosis analysis and mitochondria analysis were performed to reveal the role and underlying mechanisms of ADE in NSCLC cell lines (H460 and H1650). In vivo , xenograft model and lung metastatic model were performed to verify the effect of ADE on the growth and metastasis of NSCLC. Results In this present study, we demonstrated that treatment with ADE could inhibit cell growth and metastases through eliciting ferroptosis in vitro an in vivo . The IC50 of ADE in H460 and H1650 cells were 33.16 μM and 32.45 μM respectively. In Lewis xenografted animals, i.p. ADE repressed relative tumor growth ( P <0.01) and inhibited metastases ( P <0.01). Notably, the ferroptosis inhibitor Fer-1 abrogated the anti-tumor capacity of ADE. Induction of ferroptosis by ADE was confirmed by elevated levels of reactive oxygen sepsis (ROS), glutathione (GSH), malondialdehyde (MDA), intracellular iron content and lipid ROS reduced glutathione (GSH) accumulation ( P <0.01). Furthermore, ADE inhibited the expression of ferroptosis-related protein GPX4 and SLC7A11. Simultaneously, it also disclosed that ADE enhanced mitochondrial dysfunction, as evidenced by increased mitochondrial ROS release, mitochondrial membrane potential (MMP) depolarization, and decreased mitochondrial ATP. Most interestingly, Mito-TEMPO, a mitochondria-targeted antioxidant, rescued ADE-induced ferroptosis. Conclusion Our data validated that ADE treatment could restrain proliferation and metastases of NSCLC cells through induction of ferroptosis via potentiating mitochondrial dysfunction.

Metavanadate suppresses desferrioxamine-induced leukemic cell differentiation with reduced hypoxia-inducible factor-1alpha protein.

Desferrioxamine induces leukemic cell differentiation potentially by hypoxia-inducible factor-1 α that augments transcriptional activity of CCAAT/enhancer-binding protein- α

Desferrioxamine Induces Leukemic Cell Differentiation Potentially by Hypoxia-Inducible Factor-1 Alpha That Augments Transcriptional Activity of Ccaat/Enhancer-Binding Protein-Alpha

Hypoxia-mimetic Agents Desferrioxamine and Cobalt Chloride Induce Leukemic Cell Apoptosis Through Different Hypoxia-Inducible Factor-1Α Independent Mechanisms

Hypoxia-simulating Agents and Selective Stimulation of Arsenic Trioxide-Induced Growth Arrest and Cell Differentiation in Acute Promyelocytic Leukemic Cells.

FOXP3 Targets KIF5A to Increase Lactate Production and Promote Docetaxel Resistance in Lung Adenocarcinoma

Cobalt Chloride and Low Oxygen Tension Trigger Differentiation of Acute Myeloid Leukemic Cells: Possible Mediation of Hypoxia-Inducible Factor-1Α

Pharmacological inhibition of dihydroorotate dehydrogenase induces apoptosis and differentiation in acute myeloid leukemia cells

Deferoxamine Inhibits Iron-Uptake Stimulated Osteoclast Differentiation by Suppressing Electron Transport Chain and MAPKs Signaling.

The AhR agonist VAF347 augments retinoic acid-induced differentiation in leukemia cells

Targeting Mitochondrial Iron Metabolism Suppresses Tumor Growth and Metastasis by Inducing Mitochondrial Dysfunction and Mitophagy

Deferoxamine Enhanced Mitochondrial Iron Accumulation and Promoted Cell Migration in Triple-Negative MDA-MB-231 Breast Cancer Cells Via a ROS-Dependent Mechanism

Hypoxia-Inducible Factor-1 Alpha Blocks Differentiation of Malignant Gliomas

Hypoxia-HIF-1α-C/EBPα/Runx1 signaling in leukemic cell differentiation

Deferoxamine Suppresses Esophageal Squamous Cell Carcinoma Cell Growth Via ERK1/2 Mediated Mitochondrial Dysfunction

Hypoxia-inducible Factor-1Α-induced Differentiation of Myeloid Leukemic Cells is Its Transcriptional Activity Independent

Effect of Iron Chelator on Related Genes Expression of Apoptosis in K562 Cells

Andrographolide promoted ferroptosis to repress the development of non-small cell lung cancer through activation of the mitochondrial dysfunction

Desferoxamine protects against glucocorticoid‐induced osteonecrosis of the femoral head via activating HIF‐1α expression

Deferasirox, an iron chelator, impacts myeloid differentiation by modulating NF-kB activity via mitochondrial ROS

Effects of iron deprivation on multidrug resistance of leukemic K562 cells.